| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Exagen Diagnostics (EXDX) | Leerink Partners/ Baird | $69.00 | n.a. | |||
| Hanson Building Products (TBA) | BofA Merrill Lynch/ BNP PARIBAS/ Deutsche Bank Securities | $100.00 | n.a. | |||
| NeuroDerm, Ltd. (NDRM) | Jefferies/ Cowen and Company | $65.00 | n.a. | |||
| Proteon Therapeutics (PRTO) | Stifel/ JMP Securities | $69.00 | n.a. | |||
| Sientra (SIEN) | Piper Jaffray/ Stifel | $86.25 | n.a. | |||
| Sky Solar Holdings (SKYS) | FBR/ Cowen and Company | $100.00 | n.a. | |||
| Tantech Holdings Ltd. (TANH) | Newbridge Securities Corporation | 1.60 | $4.00 | $6.00 | $8.00 | n.a. |
| Triumph Bancorp (TBK) | Sandler O’Neill & Partners/ Evercore Group | $100.00 | n.a. | |||
| Postponed | ||||||
| rEVO Biologics (RBIO) | Piper Jaffray/ Guggenheim Securities | 3.60 | $13.00 | $15.00 | $50.40 | 1-Star |
| Withdrawn | ||||||
| Isola Group (ISLA) | UBS Investment Bank/ Piper Jaffray | $100.00 | 1-Star | |||
| Live Oak Bancshares (LOB) | Keefe, Bruyette & Woods (A Stifel Company) | $86.25 | n.a. | |||
| Microlin Bio (MCLB) (u) | Brean Capital/ Sunrise Securities | 5.50 | $4.50 | $5.50 | $27.50 | 1-Star |
| u = unit offering | ||||||
| New Terms | ||||||
| Antero Midstream Partners LP (AM) | Barclays/ Citigroup/ Wells Fargo Securities | $750.00 | n.a. | |||
| Calithera Biosciences (CALA) | Citigroup/ Leerink Partners/ Wells Fargo Securities/ JMP Securities | 6.00 | $13.00 | $15.00 | $84.00 | n.a. |
| Civitas Therapeutics (CVTS) | J.P. Morgan/ BofA Merrill Lynch | 4.00 | $14.00 | $16.00 | $60.00 | 2-Stars |
| CONE Midstream Partners LP (CNNX) | Wells Fargo Securities/ BofA Merrill Lynch/ Baird | 17.50 | $19.00 | $21.00 | $350.00 | 2-Stars |
| Dermira (DERM) | Citigroup/ Leerink Partners | 5.35 | $14.00 | $16.00 | $80.25 | n.a. |
| Medley Management (MDLY) | Goldman Sachs/ Credit Suisse | 6.00 | $20.00 | $22.00 | $126.00 | 2-Stars |
| Vantage Energy (VEI) | Barclays/ Goldman Sachs | 23.55 | $24.00 | $27.00 | $600.53 | 1-Star |
| Vivint Solar (VSLR) | Goldman Sachs/ BofA Merrill Lynch/ Credit Suisse | 20.60 | $16.00 | $18.00 | $350.20 | n.a. |
| VWR Corp (VWR) | BofA Merrill Lynch/ Goldman Sach/ J.P. Morgan | 25.53 | $22.00 | $25.00 | $600.00 | n.a. |
| Wayfair (W) | Goldman Sachs/ BofA Merrill Lynch/ Citigroup | 11.00 | $25.00 | $28.00 | $291.50 | n.a. |
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Sept. 15, 2014 | Manager(s) | Offered | Raised | Price | 9/19/14 | Change |
| Alibaba Group Holding (BABA) | Credit Suisse/ Deutsche Bank Securities/ Goldman Sachs/ J.P. Morgan/ Morgan Stanley/ Citi | 320.10 | $21,766.87 | $68.00 | $93.89 | 38.07% |
| Tokai Pharmaceuticals (TKAI) | BMO Capital Markets/ Stifel/ William Blair | 6.48 | $97.20 | $15.00 | $18.39 | 22.60% |
| Civitas Solutions (CIVI) | Barclays/ Jefferies/ BofA Merrill Lynch/ UBS Investment Bank | 11.70 | $198.90 | $17.00 | $16.49 | -3.00% |
| ProQR Therapeutics B.V. (PRQR) | Leerink Partners/ Deutsche Bank Securities | 7.50 | $97.50 | $13.00 | $16.37 | 25.92% |
| Foamix Ltd. (FOMX) | Barclays/ Cowen and Company | 6.70 | $40.20 | $6.00 | $6.15 | 2.50% |
